PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

FDA says not yet to Ipsen rare bone disease drug

French drugmaker Ipsen announced last week that the FDA had responded to the New Drug application for its fibrodysplasia ossificans progressiva (FOP) thera...
Continue Reading →
News

Amgen inks $1.25B ADCs deal with LegoChem Biosciences

South Korean-based biotech LegoChem Biosciences (LCB) revealed this week that it has entered a $1.25 billion research collaboration and license agreement w...
Continue Reading →
News

Moderna to expand UK manufacturing capabilities

Last week, mRNA king Moderna revealed plans to build a UK research, development, and manufacturing facility. Moderna said the facility should be up and ...
Continue Reading →
News

Gilead gets FDA nod for multi-drug resistant HIV treatment

The U.S. FDA has approved Gilead's Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients whose HIV infections cannot be succes...
Continue Reading →
News

Mainz recruits first patient into biomarker research

ColoAlert research could identify advanced adenomas among colorectal cancer patients. Mainz Biomed – a company specialising in the early detection of cancer – has...
Continue Reading →
News

Verona Pharma’s ensifentrine meets COPD objectives

Therapy shows a quality of life boost and significant improvement in lung function. Verona Pharma has announced positive results from its phase 3 ENHANCE-1 trial....
Continue Reading →
News

hVIVO delivers promising results for Imutex’s mosquito vaccine

AGS-v PLUS contains five synthetic peptides that originate from proteins found in mosquito saliva. hVIVO – a company that focuses on testing infectious and respir...
Continue Reading →
News

AstraZeneca’s Forxiga recommended in EU for chronic heart failure

The drug is the first heart failure medication to provide mortality benefit across the entire ejection fraction range. AstraZeneca’s Forxiga (dapagliflozin) has b...
Continue Reading →
News

Pfizer and Anumana boost detection of cardiovascular disease

The partnership will support the development of a new algorithm and identify at-risk patients. Artificial intelligence (AI) health technology company, Anumana, wi...
Continue Reading →
News

MinervaX reveals financing to development group B streptococcus vaccine

Plans include phase 3 clinical development of a novel GBS vaccine and an efficacy evaluation. MinervaX – a company developing a novel vaccine against group B stre...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026